Long-term Survival Outcomes of Surgical Resection for Lung Adenocarcinoma with Intraoperatively Diagnosed Pleural Metastasis: Target Treatment Era
Open Access
- 15 October 2025
- journal article
- Published by Korean Cancer Association in Cancer Research and Treatment
- Vol. 57 (4) , 981-988
Abstract
Purpose This study aimed to evaluate the clinical impact of main tumor resection on long-term survival compared with pleural biopsy alone in patients with lung adenocarcinoma who were intraoperatively diagnosed with pleural metastasis.Materials and Methods A total of 176 patients with adenocarcinoma who had unexpected pleural metastasis detected during surgery from 2002 to 2021 were retrospectively analyzed. Each surgeon decided whether to perform main tumor resection or pleural biopsy alone.Results The patients were grouped based on the surgical approaches: main tumor resection (resection group; n=83) and pleural biopsy only (O&C group; n=93). The resection group had better overall survival (OS; 10-year survival, 27.9% vs. 9.4%; median survival, 68.3 vs. 36.6 months; p < 0.01) and locoregional progression-free survival (10-year survival, 12.5% vs. 7.1%; median survival, 19.6 vs. 10.6 months; p < 0.01) than the O&C group. Similar results were found for OS in patients who received tyrosine kinase inhibitors (TKIs) as first-line therapy (10-year survival, 49.2% vs. 15.0%; median survival, 72.2 vs. 45.4 months; p=0.03), patients who did not undergo TKIs treatment (10-year survival, 29.4% vs. 9.2%; median survival, 82.4 vs. 23.8 months; p < 0.01), and patients with positive target gene mutation (10-year survival, 31.7% vs. 10.1%; median survival, 72.2 vs. 33.7 months; p < 0.01). In multivariate analysis, pleural biopsy only (hazard ratio, 1.73; p=0.04) was a significant predictor of OS.Conclusion Main tumor resection can improve survival in patients with lung adenocarcinoma who had unexpected pleural metastasis during operation.Keywords
This publication has 9 references indexed in Scilit:
- Salvage surgery in lung cancer following definitive therapiesJournal of Surgical Oncology, 2023
- Surgical choice of non-small cell lung cancer with unexpected pleural dissemination intraoperativelyBMC Cancer, 2021
- Primary tumor resection of non-small cell lung cancer patients with ipsilateral pleural dissemination (M1a) in the era of targeted therapyThoracic Cancer, 2020
- Long-term outcomes of upfront surgery in patients with resectable pathological N2 non-small-cell lung cancerEuropean Journal of Cardio-Thoracic Surgery, 2020
- Is surgical resection of primary tumour superior to exploratory thoracotomy without resection in treating lung cancer patients with unexpected pleural metastasis detected during operation?Interactive CardioVascular and Thoracic Surgery, 2020
- Lung adenocarcinoma with intraoperatively diagnosed pleural seeding: Is main tumor resection beneficial for prognosis?The Journal of Thoracic and Cardiovascular Surgery, 2018
- Effect of postoperative systemic therapy on pulmonary adenocarcinoma with unexpected pleural spread detected during thoracotomy or thoracoscopyOncotarget, 2017
- The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung CancerJournal of Thoracic Oncology, 2016
- Surgical Outcomes after Pulmonary Resection for Non–Small Cell Lung Cancer with Localized Pleural Seeding First Detected during SurgeryThe Thoracic and Cardiovascular Surgeon, 2015